2026/01/21
The 2025 Seoul International Invention Fair (SIIF) took place on December 3rd at the COEX exhibition center in Seoul. The Taiwan delegation, led by the Taiwan Invention Association, showcased a total of 125 outstanding works. Lytone Enterprise, Inc. (Stock Code: 1293), leveraging its profound R&D foundation in the field of "Patented Nutraceutical Compounds," delivered an exceptional performance. Two of the company's independently developed patented technologies were honored with Gold and Silver medals, once again demonstrating Lytone's innovative capabilities in functional ingredient development to the international community.
Lytone Enterprise has long been dedicated to the development of Nutraceutical Premixes, advocating for the creation of synergistic effects through the scientific proportioning of various natural ingredients to address multiple health needs. This research direction not only aligns with global health industry trends but also earned high praise from international judges at the 2025 Seoul International Invention Fair for the following two patented technologies:


The year 2025 has been a fruitful one for Lytone’s R&D achievements. Relying on its superior technology in patented nutraceutical compound development, Lytone has garnered a total of 5 Gold medals, 2 Silver medals, and 3 Special Awards across various major international invention fairs, earning deep recognition from global experts. Lytone firmly believes that these consecutive awards serve as a driving force for the R&D team’s continuous innovation. In the future, the company will continue to cultivate the field of "scientific evidence," deepen its global patent portfolio, and develop diversified functional ingredients to contribute more precise and efficient health solutions to the global health industry.